Substantial Demand for Proprietary and Generic Drugs to Drive Pharmaceutical Chemicals

Published Date : Feb 12, 2018

ALBANY, New York, February 12, 2018 – has announced the addition of a new report titled “Pharmaceutical Chemicals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025”, to its offering. The report on the global pharmaceutical chemicals market offers a critical overview of the market dynamics, growth drivers, notable trends, share and size of key segments, emerging opportunities, and lucrative avenues.

The global pharmaceutical chemicals market stood at US$167.718.2 million in 2017 and the opportunities in the market is expected to surge to reach a worth of US$268,833.5 million by 2025. The market is estimated to register a CAGR of 6.1% from 2017 to 2025.

Various pharmaceutical chemicals used can be categorized as solvents, reagents or catalysts, KSMs or intermediates, and advanced intermediates or building blocks for active pharmaceutical ingredients (APIs). Among these, the demand for building blocks for APIs/advanced intermediates dominates the market. The central role played of APIs in drugs and the substantially rising demand for a range of APIs in several therapeutic applications are factors accounting for the dominance. The outsourcing of manufacturing of these APIs from home countries has been a prominent trend in recent years and is expected to accentuate the worldwide demand for APIs. The move is stimulated by pharmaceutical companies focusing on cost-cutting measures in drug making.

Regionally, North America is set to be the most lucrative market for pharmaceutical chemicals and accounted for the major share of the total demand in 2016. The major chunk of the demand in the region is likely to come from the U.S. and Canada. The U.S. is home to several large globally prominent players, which puts North America at the forefront of the global market.

For Sample Copy, click here:

Europe accounts for a substantial global share currently and is expected to collect attractive revenues over the assessment period. Meanwhile, Asia Pacific is an attractive market with vast latent opportunities awaiting players to capitalize on. This regional market is projected to rise at a CAGR of 10.7% during 2017–2025.

The global market is driven primarily by the substantially rising demand for pharmaceutical drugs world over. The steady improvements in healthcare in several developing nations and a burgeoning geriatric population in various developed regions are notable factors propelling the demand for pharmaceutical chemicals. The rising demand for proprietary and generic drugs is a prominent factor accentuating the global market. The striking stride made by pharmaceutical manufacturing in recent years led by rapid advances in nanotechnology is also boosting the market. These developments play a significant role in furthering research in novel therapeutics and in the expansion initiatives of drug pipeline by several prominent manufacturers.  

The sustained focus of governments in several developing economies on improving healthcare infrastructure will help in the rapid expansion of the global market over the forecast timeline. The rising prevalence of non-communicable diseases and chronic conditions in emerging economies and vast improvements in incomes of urban populations are notable factors likely to accentuate the growth of the market.

The elevated cost of manufacturing APIs and unfavorable regulatory standards in several developed regions are crucial factors likely to stifle the growth of the pharmaceuticals market. Nevertheless, the imminent patent expiration of several branded drugs is anticipated to unlock exciting prospects in the market. In addition, the markedly rising acceptance of proprietary drugs among patient populations, due to less chances of counterfeiting, bodes well for the market in the coming years.

Several players are focusing on mergers and acquisitions, in a move to consolidate their supply chains and expand their customer base. A number of small players are actively tapping opportunities in key economies of Asia Pacific, mainly on account of the cheap availability of labor. Players showcasing a position of strength include Jubilant Life Sciences Ltd., Porton Fine Chemicals, Vertellus Holdings LLC, Dishman Group, Lanxess, Johnson Matthey, BASF SE, and Lonza Group.

To order report Call Toll Free: 866-997-4948 or send an email on